期刊文献+

观察胃肠间质瘤患者实施个性化治疗方案的临床效果

Clinical Efficacy of Personalized Treatment With Gastrointestinal Stromal Tumor
下载PDF
导出
摘要 目的观察胃肠间质瘤患者实施个性化治疗方案的临床效果。方法选取我院接受治疗的40例胃肠间质瘤患者作为此次调查对象,并将其随机分为观察组与对照组,每组患者20例。对照组患者以常规治疗法进行治疗。观察组患者以个性化治疗方案进行治疗。结果观察组治疗总有效率为90%;对照组治疗总有效率为70%。组间差异具有统计意义。结论个性化治疗方案对胃肠间质瘤治疗效果显著,安全性较高,可迅速缓解患者的不适症状。 Objective To observe clinical efficacy of personalized treatment with gastrointestinal stromal tumor. Methods Selected in our hospital treated 40 cases of gastrointestinal stromal tumor patients as the investigation object,and then they were randomly divided into observation group and control group, 20 cases in each group of patients. The patients of control group were treated by routine therapy. Patients in the observation group were treated with individualized treatment plan. Results In the observation group,the total effective rate was 90%; the control group the total effective rate was 70%. Significant differences between groups,results have statistical significance. Conclusion Personalized treatment has a significant effect on the treatment of gastrointestinal stromal tumor,can relieve the patient's symptoms.
作者 王春志
出处 《中国卫生标准管理》 2015年第11期164-165,共2页 China Health Standard Management
关键词 胃肠间质瘤 个性化治疗方案 治疗 观察 Gastrointestinal stromal tumor Personalized treatment Treatment Observation
  • 相关文献

参考文献3

二级参考文献21

  • 1Cappellani A, Piccolo G, Cardi F, et al. Giant gastrointestinal stromal tumor (GIST) of the stomach cause of high bowel obstruction: surgical management [J]. World J Surg Oncol, 2013,11 : 172. 被引量:1
  • 2Beham AW, Schaefer IM, Schuler P, et al. Gastrointestinal stromal tumors [ J ]. lnt J Colorectal Dis, 2012,27 : 689-700. 被引量:1
  • 3Tateishi U, Miyake M, Maeda T, et al. CT and MRI findings in KIT-weak or KIT-negative atypical gastrointeslinal stromal tumors [J]. Eur Radiol, 2006, 16:1537-1543. 被引量:1
  • 4Ohnishi K, Sakai F, Kudoh S, et al. Twenty-seven cases of drug-induced interstitial lung disease ass:iated with imatinibmesylate [ J ]. :ukemia, 2006,20: 1162-1164. 被引量:1
  • 5Rossi SE, Erasmus J J, McAdams HP, et M. Puhnonary drug toxicity: Radiologic and pathologic manifestations [J]. Radiographics, 2000,20 : 1245-1259. 被引量:1
  • 6Wardelmann E, Merkelbach-Bruse S, Pauls K, et al. Polyelonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate[J]. Clin Cancer Res, 2006,12: 1743-1749. 被引量:1
  • 7Mian AA, Metodieva A, Badura S, et al. Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I [J]. BMC Cancer, 2012, 12:411. 被引量:1
  • 8Mahadevan D, Cooke L, Riley C, et al. A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors [J ]. Oncogene, 2007,26 : 3909-3919. 被引量:1
  • 9Thao le B, Vu HA, Yasuda K, et al. Cas-L was overexpressed in imatinib-resistant gastrointestinal stromal tumor cells [J]. Cancer Bio! Ther, 2009,8 : 683-688. 被引量:1
  • 10Janeway KA, Zhu MJ, Barretina J, et al. Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGFIR genomic amplification [J]. Int J Cancer, 2010,127: 2718-2722. 被引量:1

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部